NAGE Q1 2021 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$423M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+2.4% YoY

Gross Profit

$9M62.9% margin

Operating Income

-$7M-50.1% margin

Net Income

-$7M-50.3% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

-4.9%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$69M

Total Liabilities

$25M

Stockholders' Equity

$44M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$14M	+2.4%
Gross Profit	$9M	$8M	+11.1%
Operating Income	-$7M	-$6M	-25.0%
Net Income	-$7M	-$6M	-25.1%